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latory, 10,000 more psychiatric and 3,000 more traumatological cases). Are the
cost-savings in balance with the outcome?
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OBJECTIVES: The potential for comparative effectiveness research (CER) to char-
acterize the benefits of new, expensive pediatric therapies has expanded greatly
due to recent advances in the measurement of patient-reported outcomes(PROs)
and the rise of biomedical informatics. To enhance CER and better inform alloca-
tions of scarce health care resources, this study examines 1) how much are adults
willing to trade child health-related quality of life (HR-QoL) for reduced child mor-
tality, and 2) which HR-QoL outcomes in childhood are more preferred?METHODS:
In this discrete choice experiment (DCE), 2,000 adults from a national panel com-
plete a series of 40 paired comparisons, either choosing between child HR-QoL
outcomes and longevity or choosing between alternative child HR-QoL outcomes.
Under this pivoted partial profile design, each health problem occurs at either age
7 or 11, will last for either 6 or 12 months, and be described using adjectival state-
ments derived from the EQ-5D-Y, Behavioral Problems Index (BPI), and the National
Survey of Children with Special Health Care Needs (NS-CSHCN). RESULTS: The
study is currently being fielded.The results will address the 2 primary aims as well
as produce quality-adjusted life year (QALY) estimates for child health outcomes.
Applications of these estimates will be exemplified using the NS-CSHCN and other
available pediatric health databases. CONCLUSIONS: While much of the literature
of health valuation has focused on adult outcomes, this is the first national valua-
tion study of child HR-QoL outcomes. Future work may examine the value of a
QALY by age.
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OBJECTIVES: The concept of hospital-at-home means that home treatment is pro-
vided to patients who would otherwise have been treated in the hospital. Hospital
admissions may be shortened (early assisted discharge, EAD) or avoided. This may
lead to lower costs, but there is a risk that savings are overestimated if homecare
and other relevant outpatient costs are not taken into account appropriately or if
average or generic prices per inpatient day are applied. The objective of this study
was to assess the quality of cost analyses of hospital-at-home studies for acute
conditions published from 1996 through 2011 and to present an overview of evi-
dence on cost savings. METHODS: The Medline and NHS HEED databases were
searched. Methodological quality was assessed using the Quality of Health Eco-
nomic Studies instrument (QHES). Cost calculations were considered incorrect if
they failed to meet four criteria. Unit costs of inpatient hospital days had to be
disease-specific. The decreasing intensity of care over the course of an admission
had to be reflected in costs of inpatient days. In studies from the societal perspec-
tive, informal care costs had to be included. Violating any of these criteria leads to
overestimation of savings from hospital-at-home. Finally, follow-up had to be at
least one month in order to capture relevant downstream costs, in particular for
readmissions. RESULTS: The average QHES score was 65 (out of 100) . Only 5 out of
29 studies met all criteria and had a sufficiently clear explanation of their method-
ology. The most frequent problem was the use of average costs per inpatient hos-
pital day, which was problematic in at least 11 EAD studies. Follow-up was too
short in 13 studies. Informal care costs lacked in one study that stated to adopt a
societal perspective. CONCLUSIONS: While most studies found cost savings, these
were probably overestimated.
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OBJECTIVES: In Uganda, the number of new acceptors of family planning (FP) ser-
vices is still low, partly due to limited use of cost effective delivery approaches.
Currently, FP is delivered through community based distribution (CBD) and facility
based distribution (FBD). However, FBD remains the preferred approach despite the
effectiveness and low cost nature of CBDs. The objective of this study was to com-
pare the cost effectiveness of facility and community based provision of FP by a
non-government organization. METHODS: Cost effectiveness study was done us-
ing a providers’ perspective in an urban setting of Kampala. Cost data was collected
by reviewing available accounting records and effectiveness in couple years of
protection (CYP) was determined using client cards for the period January 2008 to
December 2010. Both approaches were analyzed using Tree-Age Pro 2011, with the
facility based approach as the comparator. Cost effectiveness was determined us-
ing a decision model based on the WHO recommended FP delivery procedures. Net
Health Benefit analysis was performed and results were subjected to sensitivity
analysis. RESULTS: CBDs had a lower cost effectiveness ratio of US $ 21.21 per CYP
compared to US $ 37.17 per CYP for the FBD approach. Counseling rates were higher
for CBDs with 95%, compared to 69% for FBDs. CBDs yielded‘ cost savings of US $
39.43 for every CYP gained compared to FBDs. CONCLUSIONS: The CBD approach
was more cost effective than FBDs in increasing FP use. Increasing community
based provision of low cost FP methods and implants is an effective way of increas-
ing FP use in poor urban settings.
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OBJECTIVES: The Turkish population health status improved significantly with the
implementation of the Health Transformation Programme (HTP) and reference
pricing system in 2004.This study analyzed pharmaceutical industry dynamics due
to these changes in Turkey since 2004. METHODS: Using data from the Turkish
Statistical Institute Industry Database (2001-2011), trends in total, production and
pharmaceutical industry production indexes were evaluated. Interrupted time se-
ries models were used to determine the effect of changes in 2004. Using the IMS
LifeLink Health Plan Claims Dataset (2004-2011), pharmaceutical market growth
rate trends were analyzed. Subgroup analysis was performed for brand, generic,
and 20-year old drugs. Both domestic and imported drug shares (units, expendi-
tures) were compared (2005-2011). RESULTS: The 2004 reference pricing system
implementation negatively affected the pharmaceutical production index, with
discounts ranging from 1% to 80% for approximately 1,000 medications based on
comparisons of biologically-equivalent products and pharmaceutical prices in five,
low-price European countries (p0.01). There were no significant changes in total
and production industry indexes. Although brand medication market shares re-
mained constant across the years (2004: 42.2%, 2011: 42.6%), unit shares signifi-
cantly increased, (2004: 12.4%, 2011: 16.9%). The opposite trend occurred in the
generic market. Although generic medication expenditures slightly increased
(2004: 14.6%, 2011: 16.2%), unit consumption decreased (2004: 13.6%, 2011: 9.7%).
The 2004-2011 trends for unit and cost shares were not significantly different for
20-year old drugs (cost share: 43.3% vs. 41.2%, unit consumption: 74.0% vs. 73.4%,
respectively). CONCLUSIONS: Changing the pricing systems with instantaneous
amendments of the regulations impacts not only the reduction of drug prices and
fiscal policy but also the structure and investments of the pharmaceutical industry.
While solutions are being developed to increase drug expenses, long-term perspec-
tive of the industry’s situation and monitoring of effects are important with respect
to sustainability.
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OBJECTIVES:The development and research in health care industry has constantly
created new medical materials which provide more functional and lower side-
effects than former medical materials, but the price become more expensive rela-
tively. In order to balance the trade-off between medical quality and cost reduction,
hospitals have to keep making critical decisions on choosing a best cost-effective-
ness of hospital materials. This study aims to develop approaches for the evalua-
tion of hospital materials. METHODS: Since it is a multi-criteria decision-making
problem, we first screen the critical factors and dichotomize them into two cate-
gories, the quantitative indicators and the qualitative indicators. The quantitative
indicators include “daily expenses”, “profits”, “consumption of quantity” and “de-
fective rate”. The qualitative indicators include “manufacture capability”, “physi-
cian preference”, “special function or design” and “safety and convenience”. We
proposed to evaluate the quantitative indicators and the qualitative indicators by
data envelopment analysis and analytic hierarchy process, respectively. RESULTS:
This study uses four items of wound dressing for effectiveness evaluation (the code
A, B, C, D to replace there’s brand names). First we accord to operation definition
from the quantitative indicators to collect relevant data, and we analysis those
data. Item A in the DEA method analysis results is the most effective, item D is the
second, and item C is the worst. The consultants compare four items in pairs from
the qualitative indicators, calculating the weighted by the relative importance of
four items. Analysis on the four qualitative indicators, item D in the AHP method
analysis results is the most effective, item A is the second, and item C is the worst.
CONCLUSIONS: The proposed approaches are able to acquire a ranking of the
effectiveness of hospital materials. Following our case study, we conclude that the
proposed approaches may serve as more objective and effective decision-support
tools for the decision makers.
PHP74
COST-OF-ILLNESS OF PATIENT-REPORTED ADVERSE DRUG EVENTS – A
POPULATION-BASED SURVEY
Gyllensten H1, Rehnberg C2, Jönsson AK3, Petzold M4, Carlsten A1, Andersson Sundell K1
1Nordic School of Public Health NHV, Gothenburg, Sweden, 2Karolinska Institutet, Stockholm,
Sweden, 3Linköping University, and County Council of Östergötland, Linköping, Sweden,
4University of Gothenburg, Gothenburg, Sweden
OBJECTIVES: To estimate the cost of illness (COI) of self-reported adverse drug
events (ADE) and the COI resulting from self-reported adverse drug reactions (ADR)
and sub-therapeutic effects of medication therapy (STE), from the health care per-
spective in a population-based study. METHODS: In 2010, a random sample of
14,000 Swedish residents, aged 18 years and older, received a cross sectional postal
survey, including questions about experienced ADEs (ADRs, STEs, untreated indi-
cations, drug dependence, and drug intoxications), overall health care use and
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